Investors

[From 2021] Conditions permitting, we plan to host the conference both in-person in London and virtually. This year marks the 12th anniversary of the largest healthcare-dedicated conference in Europe. In 2020, we hosted over 550 participating companies, 3,000 attendees, and 6,500 business-to-business and investor meetings. Our conference will again feature leading public and private companies from the pharmaceuticals, biotechnology, medical technology, and healthcare services sectors from the Americas, Europe, Middle East, Africa, Asia, and Australia.

Europe’s premier international showcase for financial dealmakers and biopharma executives to meet rising biotechs – join the discussion in Dublin, or attend from home via a digital pass. Plus take advantage of two bonus days of digital 1×1 meetings. Additional details to be released shortly, check back for updates.

[From 2021] The BIO Investor Forum Digital is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and BIO One-on-One Partnering™ meetings.

Bio Connections Australia explores drug development, early phase clinical trials, translational research and expediting Australia’s great science into commercialization.

For more than 20 years, the BIO CEO & Investor Conference has fueled the biotech industry networking with premier investor and banking communities, focused on established and emerging publicly traded and select private biotech companies. 

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies, where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry.